No Involvement of Nitric Oxide in the Limitation of Beta-adrenergic Inotropic Responsiveness During Ischemia
Overview
Physiology
Affiliations
We tested whether or not endogenous nitric oxide (NO) attenuates beta-adrenergic inotropic responsiveness during normoperfusion or moderate myocardial ischemia. In 13 anesthetized pigs with a cannulated left anterior descending (LAD) coronary artery, the maximal contractile responses to intracoronary dobutamine and calcium were assessed during normoperfusion and at the end of a 90-min period of moderate ischemia (50% reduction in coronary arterial inflow) without (group 1, n = 6) and with (group 2, n = 7) prior inhibition of NO synthesis [30 mg/kg iv N(omega)-nitro-L-arginine (L-NNA)]. Contractile function was assessed by a regional work index (sonomicrometry, micromanometry, mm. mmHg). In groups 1 and 2 during normoperfusion, the maximal increase of the work index was greater with calcium than with dobutamine. At the end of ischemia in group 1, the baseline work index was decreased by approximately 50%, and the subsequent maximal increase of the work index with dobutamine, but not with calcium, was reduced compared with normoperfusion. In group 2 during normoperfusion, L-NNA did not alter the maximal increases of the work index with dobutamine or calcium. At the end of ischemia, the baseline work index was reduced by 64%, and the subsequent maximal increases of the work index with both dobutamine and calcium were reduced compared with normoperfusion; however, the response to calcium was still greater than that to dobutamine. We conclude that endogenous NO does not limit beta-adrenergic inotropic responsiveness in normoperfused or moderately ischemic porcine myocardium.
Mosqueira M, Konietzny R, Andresen C, Wang C, H A Fink R Basic Res Cardiol. 2021; 116(1):18.
PMID: 33728868 PMC: 7966140. DOI: 10.1007/s00395-021-00860-0.
Jang J, Chun J, Godo S, Wu G, Shimokawa H, Jin C Basic Res Cardiol. 2015; 110(3):21.
PMID: 25804308 PMC: 4827156. DOI: 10.1007/s00395-015-0477-6.
Cardiac NO signalling in the metabolic syndrome.
Pechanova O, Varga Z, Cebova M, Giricz Z, Pacher P, Ferdinandy P Br J Pharmacol. 2014; 172(6):1415-33.
PMID: 25297560 PMC: 4369254. DOI: 10.1111/bph.12960.
Kruzliak P, Pechanova O, Kara T Heart Fail Rev. 2013; 19(3):383-90.
PMID: 23712508 PMC: 3976759. DOI: 10.1007/s10741-013-9397-4.
Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.
van de Sandt A, Windler R, Godecke A, Ohlig J, Zander S, Reinartz M Basic Res Cardiol. 2013; 108(2):330.
PMID: 23397596 PMC: 3597270. DOI: 10.1007/s00395-013-0330-8.